Biosimilar Trastuzumab Injection from Mexico
Biosimilar trastuzumab is a monoclonal antibody targeting HER2, used for treating HER2-positive cancers such as breast cancer. It is supplied as an injection in measured doses for retail sale, qualifying under tariff item 3002.15.00 as an interchangeable immunological product. This product directly regulates immunological processes in cancer therapy.
Duty Rate — Mexico → Canada
0%
Import Tips
• Provide evidence of biosimilarity and regulatory approval from Health Canada
• Ensure retail packaging includes measured doses for tariff classification
• Have product documentation ready for CBSA to verify the immunological nature